A Lyme-Literate Physician’s Sample: The Causes and Treatment of Fatigue

Allopathic (MD) and Natural Treatments Used for Severe Fatigue Across Many Etiologies Such as Lyme Disease, Babesia, and Bartonella, ME/CFS, Long COVID/Post-Viral, Cancer-Related Fatigue, and Many Others

Sample Excerpt From Natural Medicine Book

1. Prioritized task planning with rest breaks
2. Sleep hygiene program (consistent schedule, wind-down)
3. Structured graded return-to-activity only within symptom-limited pacing (avoid fixed “GET” in ME/CFS)
4. Occupational therapy for fatigue management
5. Cognitive-behavioral therapy for fatigue in cancer and chronic illness
6. Mindfulness-based stress reduction for fatigue
7. Acceptance and commitment therapy for fatigue coping
8. Diet quality optimization (adequate protein, whole foods)
9. Hydration optimization
10. Alcohol reduction/abstinence trial
11. Caffeine timing strategy (morning/early afternoon only)
12. Heat management/cooling strategies (MS/heat-sensitive fatigue)
13. Fatigue diary with trigger identification
14. Return-to-work accommodations/graded duties

Sleep and Circadian Interventions

16. Cognitive-behavioral therapy for insomnia (CBT-I)
17. Morning bright light therapy (circadian advance)
18. Evening blue-light reduction
19. Timed melatonin for circadian phase disorders
20. Melatonin prolonged release for sleep maintenance
21. Ramelteon (melatonin receptor agonist)
22. Low-dose doxepin for sleep maintenance
23. Dual orexin receptor antagonists (e.g., daridorexant, lemborexant, suvorexant)
24. Sleep apnea treatment: CPAP/APAP
25. Mandibular advancement device (mild-moderate OSA)
26. Positional therapy for positional OSA
27. Referral for periodic limb movement disorder/restless legs treatment
28. Iron repletion for RLS with low ferritin
29. Sleep study when indicated (OSA, narcolepsy, PLMD)
30. Wake-promoting schedule for shift work (planned naps, light, melatonin)

Hematologic/Nutritional/Endocrine Corrections

31. Treat iron deficiency (oral iron)
32. Intravenous iron for intolerance/severe deficiency
33. Treat vitamin B12 deficiency (oral or parenteral)
34. Treat folate deficiency
35. Treat hypothyroidism (levothyroxine)
36. Treat adrenal insufficiency (physiologic glucocorticoid replacement; specialist)
37. Correct vitamin D deficiency
38. Address protein-calorie malnutrition
39. Manage diabetes with glycemic optimization
40. Address chronic kidney disease-related anemia (ESA/iron per guidelines)
41. Treat inflammatory anemia via disease control
42. Treat celiac disease with gluten-free diet if confirmed
43. Treat hemochromatosis-related fatigue via phlebotomy
44. Address hypogonadism when clinically indicated
45. Address obesity-related fatigue with comprehensive weight management

Cardiovascular/Orthostatic Intolerance (Including POTS/Orthostatic Hypotension)

46. Increased fluids intake protocol
47. Increased salt intake (if appropriate)
48. Compression garments (waist-high 20–30 mmHg)
49. Physical counter-maneuvers (leg crossing, tensing)
50. Reclined/recumbent aerobic reconditioning program
51. Fludrocortisone (volume expansion; specialist)
52. Midodrine (alpha-1 agonist)
53. Droxidopa (neurogenic OH)
54. Low-dose beta blockers (e.g., propranolol) for tachycardia control
55. Ivabradine (sinus rate control; select POTS)
56. Pyridostigmine (autonomic augmentation)
57. Desmopressin short-term in select cases (supervised)
58. Sleep with head-of-bed elevation
59. Treat venous insufficiency contributing to pooling

Neurostimulants and Wake-Promoting Agents (Context-Specific)

60. Modafinil (sleep disorders, select cancer/MS fatigue)
61. Armodafinil
62. Methylphenidate (cancer-related fatigue; ADHD comorbidity)
63. Lisdexamfetamine/dextroamphetamine (select cases; off-label for fatigue)
64. Pitolisant (H3 antagonist; narcolepsy-related fatigue)
65. Solriamfetol (narcolepsy/OSA residual sleepiness)
66. Amantadine (MS/post-viral fatigue; mixed evidence)
67. Caffeine/coffee strategic use
68. Nicotine replacement for withdrawal-related fatigue (short-term, cessation aid)
69. Bupropion (dopaminergic/noradrenergic; depression with fatigue)

Antidepressants/Anxiolytics When Mood/Anxiety Contribute

70. SNRIs (duloxetine, venlafaxine) for depression/anxiety with pain/fatigue
71. SSRIs (e.g., sertraline, escitalopram) for depression/anxiety with fatigue
72. Mirtazapine (sleep/pain comorbidity)
73. Tricyclics low dose (amitriptyline/nortriptyline) for pain/sleep
74. Buspirone (anxiety-related fatigue)
75. Psychotherapy (CBT/interpersonal therapy) for depression/anxiety

Pain, Inflammation, and Rheumatologic Contributors

76. Optimize analgesia per pain phenotype (acetaminophen, NSAIDs as appropriate)
77. SNRIs for neuropathic/fibromyalgia pain
78. Gabapentin/pregabalin for neuropathic pain and sleep
79. Low-dose naltrexone (fibromyalgia/ME/CFS; emerging evidence)
80. Treat inflammatory arthritis (DMARDs/biologics)
81. Treat polymyalgia rheumatica/temporal arteritis per guidelines
82. Migraine prevention (beta blockers, topiramate, CGRP mAbs) to reduce fatigue burden
83. Physical therapy and graded strengthening for chronic pain deconditioning
84. Multidisciplinary pain rehabilitation programs

Infectious, Post-Infectious, and Long COVID-Related Approaches

85. Evidence-based treatment of specific infections (e.g., antivirals/antibiotics as indicated)
86. Symptom-titrated rehabilitation and pacing (avoid push-crash)
87. Breathing retraining for dysfunctional breathing
88. Autonomic rehabilitation for dysautonomia in long COVID
89. Antihistamines H1/H2 trial (emerging/limited evidence in long COVID)
90. Intranasal corticosteroids for chronic rhinosinusitis-related fatigue
91. Vaccination updates to reduce recurrent illness burden

Neurologic and MS-Related Fatigue

92. Optimize disease-modifying therapy in MS
93. Amantadine for MS fatigue
94. Modafinil for MS fatigue (mixed evidence)
95. Dalfampridine for MS walking—may indirectly impact fatigue
96. Cooling vests/strategies for heat-sensitive MS fatigue

Oncology and Palliative Care (Cancer-Related Fatigue, CRF)

97. Supervised aerobic and resistance exercise during/after treatment
98. Psychosocial interventions (CBT, mindfulness) for CRF
99. Acupuncture for CRF (adjunct)
100. American ginseng (Panax quinquefolius) for CRF
101. Methylphenidate short-term for CRF (select)
102. Modafinil/armodafinil in CRF (mixed/conditional)
103. Erythropoiesis-stimulating agents in chemotherapy-induced anemia per guidelines
104. Treat hypothyroidism induced by immunotherapy/RT
105. Sleep disorder screening and management in cancer care

Respiratory and Other Organ-System Contributors

106. Optimize asthma/COPD control
107. Pulmonary rehabilitation (COPD/ILD)
108. Treat heart failure per guideline-directed therapy
109. Treat chronic liver disease complications (hepatic encephalopathy, lactulose/rifaximin)
110. Address obstructive uropathy/nocturia disrupting sleep

Natural Products and Nutraceuticals (Quality-Controlled; Target Deficiencies)

111. Coenzyme Q10 (and/or ubiquinol)
112. NADH or NAD precursors (e.g., nicotinamide riboside; mixed evidence)
113. Creatine monohydrate
114. Riboflavin (B2)
115. Thiamine (B1), especially in high-carb diets or post-infectious states
116. Magnesium (glycinate/citrate)
117. Omega-3 fatty acids (EPA/DHA)
118. Acetyl-L-carnitine (mixed; avoid in certain chemo neuropathies)
119. L-carnitine in dialysis-related fatigue
120. Alpha-lipoic acid (neuropathic pain/energy; mixed evidence)
121. Ashwagandha (Withania somnifera) adaptogen
122. Rhodiola rosea adaptogen
123. Panax ginseng
124. American ginseng (CRF evidence)
125. Eleutherococcus senticosus (eleuthero)
126. Cordyceps militaris/sinensis extracts (preliminary data)
127. Ganoderma lucidum (reishi; sleep/immune modulation)
128. Bacopa monnieri (cognitive fatigue; mixed)
129. Saffron (mood-related fatigue)
130. L-theanine (sleep quality/anxiety)
131. Beetroot juice (dietary nitrates for exercise tolerance)
132. Tart cherry concentrate (sleep/DOMS recovery)
133. Vitamin C repletion in deficiency or after infection
134. Vitamin B12 supplementation when low-normal with symptoms (individualized)
135. Protein supplementation if intake is low
136. Mediterranean diet pattern
137. Low–FODMAP elimination/rechallenge when IBS-driven fatigue prominent
138. Probiotics (strain-specific; e.g., B. lactis HN019) for gut symptoms that worsen fatigue
139. Anti-inflammatory spice adjuncts (curcumin; mixed for fatigue)
140. Sunlight/outdoor time (light + activity + mood effects)

Physical and Mind-Body Therapies

141. Tai chi for chronic illness-related fatigue
142. Yoga (gentle/restorative forms)
143. Qigong
144. Acupressure/self-acupressure routines
145. Massage therapy
146. Breathing techniques (slow diaphragmatic, CO2 tolerance)
147. Guided imagery/relaxation training
148. Biofeedback for autonomic balance
149. Cognitive remediation/compensatory strategies for brain fog
150. Heat/cold contrast hydrotherapy (symptom management)

Medical Processes That Reduce Fatigue Drivers

151. Medication deprescribing to remove sedating/anticholinergic burden
152. Switch from sedating antihypertensives to alternatives when appropriate
153. Treat chronic infections/inflammation (sinusitis, periodontitis) when present
154. Correct vision/hearing deficits to reduce cognitive load
155. Address sleep-interfering nocturia (urology management)
156. Treat perimenopausal symptoms affecting sleep (e.g., CBT-I, hormone therapy when appropriate)
157. Treat seasonal affective disorder with light therapy
158. Address GERD/night reflux that fragments sleep
159. Manage allergies/rhinitis that impair sleep and breathing
160. Smoking cessation with structured program (fatigue improves over weeks)

Procedural and Specialized

161. Iron infusion clinics for refractory deficiency
162. Autonomic testing and targeted therapy for dysautonomia
163. Cardiac rehab for post-cardiac event fatigue
164. Post-ICU syndrome rehabilitation programs
165. Multidisciplinary long COVID clinics (individualized plans)
166. Sleep dentistry for mandibular advancement devices
167. Neuromodulation trials in select conditions (investigational; specialist)

References (Selected, Full Citations)

National Institute for Health and Care Excellence (NICE). Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management. NICE Guideline NG206. 2021.

Centers for Disease Control and Prevention. ME/CFS: Clinical Care. Updated 2023.

World Health Organization. Post COVID-19 condition (Long COVID): key facts. 2023.

Raj SR, Guzman JC, Harvey P, et al. Canadian Cardiovascular Society Position Statement on POTS and related disorders of orthostatic intolerance. Can J Cardiol. 2020;36(3):357–372. doi:10.1016/j.cjca.2019.12.024

Vernino S, Bourne KM, Stiles LE, et al. Autonomic Disorders Consortium statement on POTS diagnosis and management. Auton Neurosci. 2021;235:102828. doi:10.1016/j.cjautneu.2021.102828

Qaseem A, Kansagara D, Forciea MA, et al. Management of chronic insomnia disorder in adults: ACP clinical practice guideline. Ann Intern Med. 2016;165(2):125–133. doi:10.7326/M15-2175

Ramar K, Malhotra RK, Carden KA, et al. AASM clinical practice guideline for diagnostic testing for adult OSA. J Clin Sleep Med. 2017;13(3):479–504. doi:10.5664/jcsm.6506

Wilt TJ, MacDonald R, Brasure M, et al. Pharmacologic therapy for OSA: a systematic review. Ann Intern Med. 2013;159(7):489–498. doi:10.7326/0003-4819-159-7-201310010-00006

Young T, Finn L, Peppard PE, et al. Sleep disordered breathing and fatigue. Am J Respir Crit Care Med. 2002;165(9):1217–1221. doi:10.1164/rccm.2101001

Verdon F, Burnand B, Stubi CL, et al. Iron supplementation for unexplained fatigue in non-anaemic women: double-blind RCT. BMJ. 2003;326:1124. doi:10.1136/bmj.326.7399.1124

Krayenbuehl PA, Battegay E, Breymann C, et al. Intravenous iron for fatigue in non-anaemic, iron-deficient women: RCT. Blood. 2011;118(12):3222–3227. doi:10.1182/blood-2011-04-348755

Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for hypothyroidism in adults: ATA/AACE. Thyroid. 2014;24(12):1670–1751. doi:10.1089/thy.2014.0028

Nowak A, Boesch L, Andres E, et al. Vitamin D supplementation and fatigue: RCT in vitamin D-deficient individuals. Medicine (Baltimore). 2016;95(52). doi:10.1097/MD.0000000000005353

Saini A, Miller CJ, Gannon MC, et al. Erythropoiesis-stimulating agents in chemotherapy-induced anemia. Cochrane Database Syst Rev. 2023;CD003407. doi:10.1002/14651858.CD003407.pub5

Mustian KM, Alfano CM, Heckler C, et al. Comparison of pharma, exercise, and psychological interventions for CRF: meta-analysis. JAMA Oncol. 2017;3(7):961–968. doi:10.1001/jamaoncol.2016.4919

Lyman GH, Bohlke K, Cohen L, et al. ASCO guideline on integrative medicine for oncology patients: fatigue management. J Clin Oncol. 2022;40(28):3203–3226. doi:10.1200/JCO.22.00613

Barton DL, Liu H, Dakhil SR, et al. Wisconsin ginseng for CRF: RCT. J Natl Cancer Inst. 2013;105(16):1230–1238. doi:10.1093/jnci/djt181

Puetz TW, Herring MP. Differential effects of exercise on fatigue in chronic illness: meta-analysis. Psychol Bull. 2012;138(6):988–1015. doi:10.1037/a0027880

Cella D, Davis K, Breitbart W, Curt G. Cancer-related fatigue: prevalence and screening. Oncologist. 2001;6(Suppl 1):9–16. doi:10.1634/theoncologist.6-suppl_1-9

Yang C, White DP, Winkelman JW, et al. CPAP improves fatigue in OSA: RCT evidence. Sleep. 2007;30(4):511–519. doi:10.1093/sleep/30.4.511

Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. Fatigue in MS: scale development. Arch Neurol. 1989;46(10):1121–1123. doi:10.1001/archneur.1989.00520460115022

Khan F, Amatya B, Galea M, et al. MS fatigue management: systematic review. J Clin Med. 2020;9(10):3420. doi:10.3390/jcm9103420

Yang MM, Cooney LG, Ahn JS, et al. Low-dose naltrexone in fibromyalgia: systematic review. Arthritis Care Res. 2023;75(5):1076–1085. doi:10.1002/acr.24887

Castro-Marrero J, Cordero MD, Segundo MJ, et al. CoQ10 plus NADH in ME/CFS: randomized trial. Antioxid Redox Signal. 2015;22(8):679–685. doi:10.1089/ars.2014.6141

Block KI, Koch AC, Mead MN, et al. Ginseng in cancer-related fatigue: systematic review. J Natl Cancer Inst Monogr. 2014;2014(50):238–245. doi:10.1093/jncimonographs/lgu031

Darbishire L, Ridsdale L, Panayiotopoulos CP. Modafinil for MS fatigue: randomized, double-blind, crossover trial. J Neurol Neurosurg Psychiatry. 2003;74(2):192–196. doi:10.1136/jnnp.74.2.192

Asano M, Finlayson ML. Meta-analysis of pharmacologic therapies for MS fatigue. Arch Phys Med Rehabil. 2014;95(7):1221–1231. doi:10.1016/j.apmr.2014.02.009

Busija L, Bridgett L, Williams SRM, et al. Fibromyalgia management overview. Best Pract Res Clin Rheumatol. 2013;27(3):369–380. doi:10.1016/j.berh.2013.09.006

Choi CJ, Park SK, Lee YK, et al. Effect of rhodiola on fatigue: systematic review/meta-analysis. BMC Complement Altern Med. 2014;14:198. doi:10.1186/1472-6882-14-198

Lopresti AL, Smith SJ, Malvi H, Kodgule R. Ashwagandha for stress/anxiety: systematic review with fatigue outcomes. J Clin Med. 2019;8(10):1398. doi:10.3390/jcm8101398

Benton D, Donohoe RT. The influence of creatine supplementation on cognitive functioning and fatigue. Br J Nutr. 2011;105(7):1101–1113. doi:10.1017/S0007114510004733

Bloomer RJ, Smith WA. Reishi mushroom for fatigue and wellbeing: pilot data. J Altern Complement Med. 2010;16(9):971–977. doi:10.1089/acm.2009.0284

Hardeland R. Melatonin and fatigue-related conditions. Int J Mol Sci. 2012;13(2):1887–1937. doi:10.3390/ijms13021887

Morgenthaler TI, Lee-Chiong T, Alessi C, et al. Practice parameters for the clinical evaluation and treatment of circadian rhythm sleep disorders. Sleep. 2007;30(11):1445–1459. doi:10.1093/sleep/30.11.1445

Bourke R, Anderson V, Yang JS, et al. Cognitive-behavioural treatment of insomnia and fatigue in cancer survivors: RCT. J Clin Oncol. 2011;29(21):2799–2806. doi:10.1200/JCO.2010.32.7500

Karlsen TI, Tveit KS, Thorsby PM, et al. Vitamin B12 treatment for fatigue: systematic review. Br J Gen Pract. 2016;66(647)–e327. doi:10.3399/bjgp16X685285

Abaraogu UO, Dall PM, Seenan CA, et al. Tai chi and qigong for cancer-related fatigue: systematic review. Support Care Cancer. 2016;24(5):1959–1976. doi:10.1007/s00520-015-2951-6

Schünemann HJ, Cushman M, Burnett AE, et al. American Society of Hematology 2019 guidelines for sickle cell disease transfusions (fatigue implications). Blood Adv. 2019;3(23):3829–3857. doi:10.1182/bloodadvances.2019000916

Sorensen J, Rouch L, Yaffe K, et al. Deprescribing and fatigue in older adults: narrative review. Drugs Aging. 2020;37(7):509–517. doi:10.1007/s40266-020-00768-5

Malekzadeh J, Naghizadeh MM, Parsa S, et al. L-carnitine in hemodialysis-related fatigue: RCT. Iran J Kidney Dis. 2011;5(1):21–26.

Spielman AJ, Caruso LS, Glovinsky PB. Behavioral models for insomnia and fatigue. Clin Psychol Rev. 1987;7(4):381–402. doi:10.1016/0272-7358(87)90007-4

Greenhalgh T, Knight M, A’Court C, et al. Management of post-acute COVID-19 in primary care. BMJ. 2020;370. doi:10.1136/bmj.m3026

Komaroff AL, Bateman L. Will COVID-19 lead to ME/CFS? Front Med. 2021;7:606824. doi:10.3389/fmed.2020.606824

Selsick H, Olaithe M, Bucks RS, et al. Modafinil/armodafinil for residual sleepiness in OSA: meta-analysis. J Clin Sleep Med. 2021;17(11):2267–2277. doi:10.5664/jcsm.9446

Bruera E, Valero V, Driver L, et al. Methylphenidate for cancer fatigue: double-blind trial. J Clin Oncol. 2006;24(13):2073–2078. doi:10.1200/JCO.2005.03.9231

Fink JN, Loprinzi CL, Sloan JA, et al. Methylphenidate vs placebo for cancer fatigue: RCT. J Clin Oncol. 2010;28(23):3673–3679. doi:10.1200/JCO.2009.26.3248

Lim KE, Renn BN, Chan M, et al. Mindfulness-based interventions for fatigue: meta-analysis. Ann Behav Med. 2019;53(9):741–756. doi:10.1093/abm/kay090

O’Connor PJ, Puetz TW. Chronic physical activity and feelings of energy and fatigue. Psychol Bull. 2005;131(5):729–751. doi:10.1037/0033-2909.131.5.729

Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA BP guideline (medication fatigue implications). Hypertension. 2018;71(6)–e115. doi:10.1161/HYP.0000000000000065